In Reply - Lowering the High Cost of Cancer Drugs

Hagop Kantarjian; Ayalew Tefferi

doi:10.1016/j.mayocp.2015.12.016

In Reply - Lowering the High Cost of Cancer Drugs

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	401-403
Number of pages	3
Journal	Mayo Clinic proceedings
Volume	91
Issue number	3
DOIs	https://doi.org/10.1016/j.mayocp.2015.12.016
State	Published - Mar 1 2016

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/j.mayocp.2015.12.016

Cite this

@article{d0cf07cb243b43dab46f0df6a336294b,

title = "In Reply - Lowering the High Cost of Cancer Drugs",

author = "Hagop Kantarjian and Ayalew Tefferi",

year = "2016",

month = mar,

day = "1",

doi = "10.1016/j.mayocp.2015.12.016",

language = "English (US)",

volume = "91",

pages = "401--403",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "3",

}

TY - JOUR

T1 - In Reply - Lowering the High Cost of Cancer Drugs

AU - Kantarjian, Hagop

AU - Tefferi, Ayalew

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84959359059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959359059&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2015.12.016

DO - 10.1016/j.mayocp.2015.12.016

M3 - Letter

C2 - 26944248

AN - SCOPUS:84959359059

SN - 0025-6196

VL - 91

SP - 401

EP - 403

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 3

ER -

In Reply - Lowering the High Cost of Cancer Drugs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this